Japan Tobacco Aktie
26,72EUR | 1,16EUR | 4,54% |
WKN: 893151 / ISIN: JP3726800000
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 54,60 |
Government of Japan | 33,34 |
Japan Tobacco, Inc. | 11,22 |
Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 1,75 |
Nikko Asset Listed Index TOPIX ETF (1308) | 0,85 |
Vanguard Total International Stock Index Fund | 0,83 |
Daiwa Asset iFreeETF TOPIX (Yearly Dividend Type) (1305) | 0,79 |
Goldman Sachs GQG Partners International Opportunities Fund | 0,71 |
JT Group Employee Stock Ownership Plan | 0,55 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 61 975 | 58 300 | 55 381 | 52 640 | 53 239 |
Umsatz pro Mitarbeiter in Mio. EUR | 35,10 | 35,89 | 41,98 | 50,49 | 53,36 |
Bilanz (in Mio. JPY) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 925 673 | 2 003 919 | 2 321 289 | 2 723 591 | 3 259 561 |
Summe Anlagevermögen | 3 627 398 | 3 377 463 | 3 452 920 | 3 824 487 | 4 022 536 |
Summe Aktiva | 5 553 071 | 5 381 382 | 5 774 209 | 6 548 078 | 7 282 097 |
Bilanz (in Mio. JPY) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 974 502 | 1 025 412 | 979 158 | 1 018 639 | 1 201 850 |
Summe Fremdkapital | 2 809 461 | 2 781 888 | 2 888 129 | 2 931 317 | 3 369 606 |
Summe Eigenkapital | 2 743 612 | 2 599 494 | 2 886 081 | 3 616 761 | 3 912 492 |
Summe Passiva | 5 553 073 | 5 381 382 | 5 774 210 | 6 548 078 | 7 282 098 |
Adresse
2-2-1 Toranomon, 105-8422 Tokyo | |
Telefon | +81 (3) 3582-3111 |
Fax | +81 (3) 5572-1441 |
Internet | http://www.jti.co.jp |
Management
Eiichi Kiyokawa
Managing Executive Officer & Head-Sales |
Hideaki Kashiwakura
Auditor |
Hiromasa Furukawa
Chief Financial Officer & Senior VP-Communications |
Hiroshi Shimobayashi
Head-Information Technology |
Hiroyuki Fukuda
Executive Officer & Head-Communications |
Hiroyuki Miki
Executive Officer, Head-Research & Development |
Hisato Imogawa
Chief Sustainability Officer |
Junichi Fukuchi
CEO-Domestic Tobacco Business |
Kaoruaki Okamoto
Vice Chairman |
Kei Nakano
Executive Officer & Head-Corporate Strategy |
Kenji Ogura
Head-Governance & Compliance |
Kiyohide Hirowatari
Representative Director EVP & Head-Corporate |
Koji Shimayoshi
VP-Corporate Sustainability Management |
Main Kohda
Independent Outside Director |
Masamichi Terabatake
President, CEO & Representative Director |
Masato Kitera
Outside Director |
Masayuki Mishima
Head-People & Culture |
Megumi Nakano
Representative Director & Vice President |
Mutsuo Iwai
Executive Chairman |
Naohiro Minami
Executive Vice President-Finance & Communications |
Osamu Hirose
General Counsel |
Shigenori Ohkawa
Manager-Central Pharmaceutical Research Institute |
Shuichi Hirosue
Executive Officer & Head-Marketing |
Takehisa Shibayama
Executive Officer & Head-Digitalization |
Tetsuya Shoji
Outside Director |
Tsutomu Hashimoto
Auditor |
Yuki Maeda
Managing Executive Officer |
Yukiko Nagashima
Independent Outside Director |